AXT Résultats passés
Passé contrôle des critères 0/6
Les bénéfices de AXT ont diminué à un taux annuel moyen de -59.7%, tandis que le secteur Semiconductor a vu ses bénéfices augmenter de en à 1.8% par an. Les revenus ont augmenté de en baisse à un taux moyen de 9.9% par an.
Informations clés
-59.66%
Taux de croissance des bénéfices
-59.47%
Taux de croissance du BPA
| Semiconductor Croissance de l'industrie | 27.66% |
| Taux de croissance des recettes | -9.91% |
| Rendement des fonds propres | -4.35% |
| Marge nette | -14.87% |
| Dernière mise à jour des bénéfices | 31 Mar 2026 |
Mises à jour récentes des performances passées
Recent updates
Seeking Alpha • May 04
AXT Inc. Hits New All-Time Highs On Strong Earnings And Forward Outlook
Summary AXT, Inc. delivered strong Q1-2026 results driven by high demand for Indium Phosphide. AXT plans to expand its Indium Phosphide capacity over the next two years. The AXT stock price has gained 7,000% over the last year and is now extremely overvalued. I continue my rating of a hold for AXT stock. Read the full article on Seeking Alpha
Mise à jour du récit • Apr 29
AXTI: Future InP Substrate Demand Will Outweigh Near Term Export Constraints
Narrative Update on AXT The analyst price target for AXT has moved from $45 to $90, with analysts pointing to higher assumed profit margins, an increased future P/E multiple, and stronger long term InP substrate demand expectations supported by recent capacity and capex plans at major optical and cloud players. Analyst Commentary Recent Street research on AXT highlights a mix of optimism on long term InP substrate demand and some short term caution around export related constraints.
Mise à jour du récit • Apr 14
AXTI: Export Permit Limits Will Continue To Restrain InP AI Upside
Analysts have raised AXT's fair value estimate from $28.25 to $30.75, reflecting updated views on higher potential P/E multiples, supported by expected InP growth and recent price target increases from several research firms. Analyst Commentary Recent research gives you a mixed but useful read on how the Street is thinking about AXT, with some focusing on long term InP growth potential and others highlighting nearer term execution risks and regulatory overhangs.Mise à jour du récit • Mar 31
AXTI: Export Permit Constraints Will Limit Upside Despite InP Demand Story
AXT's analyst fair value estimate has been raised from $26.00 to $45.00 as analysts factor in expectations for higher revenue, stronger profit margins, and a richer forward P/E multiple supported by rising Street price targets related to InP demand and export permit clarity. Analyst Commentary Recent research on AXT points to a split view, with some caution around near term export permit issues, but also a series of more optimistic calls that connect the story to longer term compound semiconductor demand and valuation support tied to InP exposure.
Mise à jour du récit • Mar 17
AXTI: Export Permit Constraints Will Limit Benefit Of InP Demand Optimism
The analyst price target for AXT has increased from $8.50 to $21, with analysts citing stronger InP growth expectations, higher projected profit margins, and a higher assumed future P/E multiple as key supports for the updated valuation framework. Analyst Commentary Recent Street research on AXT reflects a wide spread in price targets, with some analysts using relatively high P/E multiples based on long term InP growth expectations and others taking a more cautious stance as they weigh near term execution risks and policy related constraints.Mise à jour du récit • Mar 03
AXTI: InP Export Permit Constraints Will Undermine AI Demand Upside Potential
Narrative Update on AXT The analyst price targets for AXT have moved sharply higher, with recent updates ranging from $21 to $35. Analysts are factoring in higher fair value estimates and stronger InP growth expectations, despite ongoing export permit uncertainty.Mise à jour du récit • Feb 17
AXTI: Neutral Stance Will Reflect Export Permit Risks And Equity Raise
Narrative Update on AXT Price Target Analysts have raised their AXT price target from $9 to $18, citing updated assumptions for higher revenue growth and profit margins, as well as a lower discount rate. At the same time, they have shifted to a Neutral stance following export permit related headwinds in InP substrate shipments.Mise à jour du récit • Feb 03
AXTI: Export Permit Constraints And Equity Offering Will Pressure Future Returns
Analysts have raised their price target on AXT to US$18 from US$9, citing valuation after the company adjusted its Q4 revenue outlook due to fewer export permits for InP substrates from the Chinese government. Analyst Commentary Bearish analysts are framing the new US$18 price target as less about improving fundamentals and more about the stock having already run ahead of what they see as reasonable expectations.Mise à jour du récit • Jan 20
AXTI: Export Permit Uncertainty Will Constrain Near Term Revenue Outlook
Analysts have lifted their price targets for AXT, with moves such as from US$4.10 to US$7 and from US$9 to US$18, citing changing views on export permit progress, revenue assumptions, and valuation. Analyst Commentary Recent Street research on AXT reflects a mixed backdrop, with some bearish analysts turning more cautious even as price targets move higher.Mise à jour du récit • Jan 05
AXTI: Export Permits Will Drive Fragile Near Term Revenue Expectations
Analysts lifted their price target on AXT to $7.00 from $4.10, pointing to updated Q3 revenue assumptions after the company received export permits from China's Ministry of Commerce to resume shipping indium phosphide substrates to additional customers. Analyst Commentary Analysts point to the new export permits as a key reason for revisiting their models, with Q3 revenue assumptions adjusted to reflect the potential contribution from indium phosphide substrate shipments to additional customers.Article d’analyse • Dec 19
AXT, Inc.'s (NASDAQ:AXTI) 39% Share Price Surge Not Quite Adding Up
AXT, Inc. ( NASDAQ:AXTI ) shares have continued their recent momentum with a 39% gain in the last month alone. The last...Mise à jour du récit • Dec 14
AXTI: New Export Permits Will Intensify Regulatory And Execution Downside Risks
Analysts have raised their price target on AXT by approximately $2.90 per share to around $7.00, citing improved revenue expectations after the company received new export permits that enable it to resume shipping indium phosphide substrates to additional customers. Analyst Commentary Analysts are updating their models ahead of upcoming quarterly results, reflecting the impact of newly granted export permits on AXT's near term revenue and margin profile.Mise à jour du récit • Nov 30
AXTI: Export Permit Reliance Will Heighten Downside Risks Amid Ongoing Uncertainty
Analysts have increased their price target for AXT to $7 from $4.10, citing higher anticipated revenues because the company recently obtained export permits that allow it to ship indium phosphide substrates to additional customers. Analyst Commentary Recent updates from the analyst community reflect a reassessment of AXT's growth prospects and financial outlook following the news about new export permits for indium phosphide substrates.Mise à jour du récit • Nov 16
AXTI: Renewed Export Permits Will Influence Recovery Amid Regulatory Risks
Analysts have raised AXT's fair value estimate significantly from $5.70 to $9.50 per share, citing improved revenue assumptions following renewed export permits and a higher price target in recent research updates. Analyst Commentary Analyst reactions to AXT's recent developments have brought both optimism and caution regarding the company's future prospects and valuation.Mise à jour du récit • Nov 02
AXTI: Export Permit Uncertainty Will Challenge Margin Strength Moving Forward
The analyst price target for AXT has increased significantly from $3.82 to $5.70 per share, as analysts cite improved revenue growth expectations and recent export permit approvals as key drivers behind their revised outlook. Analyst Commentary Analyst sentiment regarding AXT has evolved in response to recent company developments, with notable optimism about future growth prospects.Article d’analyse • Oct 14
AXT, Inc. (NASDAQ:AXTI) Shares Fly 26% But Investors Aren't Buying For Growth
AXT, Inc. ( NASDAQ:AXTI ) shares have continued their recent momentum with a 26% gain in the last month alone. Looking...Article d’analyse • Oct 08
Here's Why AXT (NASDAQ:AXTI) Can Afford Some Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Article d’analyse • Jul 20
AXT, Inc. (NASDAQ:AXTI) Stock Catapults 33% Though Its Price And Business Still Lag The Industry
Despite an already strong run, AXT, Inc. ( NASDAQ:AXTI ) shares have been powering on, with a gain of 33% in the last...
Nouveau récit • May 02
Chinese Data Center Demand And Laser Tech Will Open New Markets
Strategic positioning in the Chinese data center market and local sourcing aims to reduce foreign dependency and boost revenue growth.Seeking Alpha • Feb 24
AXT, Inc. Reported Improved Q4 Financial Performance But Q1 Outlook Disappoints
Summary AXT, Inc. reported increased revenues QoQ and YoY due to higher demand for its indium phosphide wafers. The company expects lower Q1 2025 revenues due to new regulations in China over exports of indium phosphide. The company’s stock price hit its 52-week low last Friday due to the weak Q1 outlook. The company still foresees strong performance during 2025 and 2026 regardless of the setback. I rate AXTI stock as a Hold for now and recommend that investors watch the company for developments. Read the full article on Seeking AlphaSeeking Alpha • Oct 26
AXT, Inc.: Not Getting The Recognition It Deserves
Summary AXT, Inc. came close to multi-year lows last September after a selloff following guidance, but history suggests that might have been a good entry point. Guidance suggests AXTI will grow slower, at least in the short term, but there is nonetheless much more to remain upbeat about. There have been setbacks, including in terms of AI, but AXTI is still growing and on pace to get back to earning a profit as soon as next year. It may take some time and patience, but long AXTI still looks like it has what it takes to become a winning play. Read the full article on Seeking AlphaSeeking Alpha • Aug 05
AXT, Inc.: Downgrading On Limited Visibility And Early Cracks In The AI Story
Summary Semiconductor substrate provider AXT, Inc. reported better-than-expected Q2/2024 results, with both revenues and profitability coming in ahead of consensus estimates. Strong sequential growth in gallium arsenide and germanium substrate sales were partially offset by a decrease in indium phosphide revenues. However, Q3 guidance came in below consensus expectations due to an anticipated sequential decline in substrate revenues. While the company looks cheap following Friday's selloff, limited visibility and a rather lumpy AI revenue ramp are likely to keep the stock in the penalty box for at least the next couple of months. Given these issues, I am downgrading the company's stock from "Buy" to "Hold". Read the full article on Seeking AlphaSeeking Alpha • Jul 21
AXT Inc.: Playing An Expected Rebound
Summary The stock has sold off in the last three days due to AXTI’s ties to China, but this could be an opportunity to take advantage of. AXTI is valued at much less than book value, which could become untenable if AXTI gets out of the red in 2025. AXTI is scheduled to release the Q2 report on August 1 and the conditions are there for a repeat of what happened twice before in 2024. The China factor will not go away anytime soon, but long AXTI has enough in its favor to make it worth backing. Read the full article on Seeking AlphaSeeking Alpha • May 07
AXT: Strong Outlook As Business Recovery Is Picking Up Steam - Buy
Summary Semiconductor substrate provider AXT, Inc. reported Q1/2024 results in line with its April 8 preannouncement and provided Q2 guidance well ahead of expectations. The company's substrate business continues to recover across all major product lines, with some AI-related demand contributing to a 50% sequential increase in indium phosphide sales. Management expects the company to reach breakeven levels by the end of this year or early next year. The company is considering monetizing some of its holdings in a number of Chinese raw materials providers. Risk/reward is looking increasingly favorable for speculative investors, with the business recovering across the board and a number of potential near- and medium-term catalysts. Reiterating "Buy" rating with a near-term price target of $5.30. Read the full article on Seeking AlphaSeeking Alpha • Apr 05
AXT: Selloff Provides Buying Opportunity
Summary A plethora of allegations raised in a new shortseller report caused AXT, Inc.'s shares to crater by 35%. The core short thesis is centering around the risks resulting from a potential failure to list Chinese subsidiary Tongmei on the Shanghai Star Market. However, these risks have been adequately disclosed by the company in recent years and should be well-known among market participants following AXT more closely. In addition, the company's business is showing early signs of life after a couple of abysmal quarters with analysts projecting a full-blown recovery for next year. In my opinion, Thursday's selloff provides speculative investors an opportunity to initiate positions in a recovering business driven by exposure to the red hot data center and AI market. Should AXT execute at least in line with current analyst expectations, the stock might approach $6 next year. Read the full article on Seeking AlphaVentilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment AXT gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 26 | 96 | -14 | 25 | 9 |
| 31 Dec 25 | 88 | -21 | 24 | 9 |
| 30 Sep 25 | 90 | -23 | 24 | 11 |
| 30 Jun 25 | 86 | -24 | 24 | 13 |
| 31 Mar 25 | 96 | -19 | 24 | 14 |
| 31 Dec 24 | 99 | -12 | 24 | 15 |
| 30 Sep 24 | 95 | -10 | 23 | 13 |
| 30 Jun 24 | 88 | -13 | 23 | 13 |
| 31 Mar 24 | 79 | -17 | 23 | 12 |
| 31 Dec 23 | 76 | -18 | 23 | 12 |
| 30 Sep 23 | 82 | -13 | 23 | 13 |
| 30 Jun 23 | 100 | -2 | 24 | 14 |
| 31 Mar 23 | 121 | 9 | 25 | 14 |
| 31 Dec 22 | 141 | 16 | 26 | 14 |
| 30 Sep 22 | 152 | 17 | 26 | 13 |
| 30 Jun 22 | 151 | 15 | 26 | 12 |
| 31 Mar 22 | 146 | 14 | 25 | 11 |
| 31 Dec 21 | 137 | 14 | 24 | 10 |
| 30 Sep 21 | 127 | 13 | 23 | 10 |
| 30 Jun 21 | 118 | 11 | 21 | 9 |
| 31 Mar 21 | 106 | 7 | 20 | 8 |
| 31 Dec 20 | 95 | 3 | 19 | 7 |
| 30 Sep 20 | 87 | -1 | 19 | 7 |
| 30 Jun 20 | 81 | -3 | 19 | 6 |
| 31 Mar 20 | 84 | -2 | 19 | 6 |
| 31 Dec 19 | 83 | -3 | 19 | 6 |
| 30 Sep 19 | 87 | -2 | 19 | 6 |
| 30 Jun 19 | 96 | 3 | 19 | 6 |
| 31 Mar 19 | 98 | 5 | 20 | 6 |
| 31 Dec 18 | 102 | 9 | 19 | 6 |
| 30 Sep 18 | 106 | 14 | 19 | 6 |
| 30 Jun 18 | 106 | 14 | 18 | 6 |
| 31 Mar 18 | 102 | 12 | 17 | 5 |
| 31 Dec 17 | 99 | 10 | 17 | 5 |
| 30 Sep 17 | 93 | 9 | 16 | 5 |
| 30 Jun 17 | 86 | 7 | 15 | 5 |
| 31 Mar 17 | 83 | 6 | 14 | 6 |
| 31 Dec 16 | 81 | 5 | 14 | 6 |
| 30 Sep 16 | 79 | 2 | 13 | 6 |
| 30 Jun 16 | 76 | 0 | 14 | 6 |
| 31 Mar 16 | 76 | -1 | 14 | 6 |
| 31 Dec 15 | 78 | -2 | 16 | 6 |
| 30 Sep 15 | 79 | -1 | 17 | 6 |
| 30 Jun 15 | 84 | -1 | 17 | 5 |
Des revenus de qualité: AXTI n'est actuellement pas rentable.
Augmentation de la marge bénéficiaire: AXTI n'est actuellement pas rentable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: AXTI n'est pas rentable et les pertes ont augmenté au cours des 5 dernières années à un rythme de 59.7% par an.
Accélération de la croissance: Impossible de comparer la croissance des bénéfices de AXTI au cours de l'année écoulée à sa moyenne sur 5 ans car elle n'est actuellement pas rentable
Bénéfices par rapport au secteur d'activité: AXTI n'est pas rentable, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Semiconductor ( 12.3% ).
Rendement des fonds propres
ROE élevé: AXTI a un retour sur capitaux propres négatif ( -4.35% ), car il n'est actuellement pas rentable.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/13 04:44 |
| Cours de l'action en fin de journée | 2026/05/13 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
AXT, Inc. est couverte par 7 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Ku Kang | B. Riley Securities, Inc. |
| Hamed Khorsand | BWS Financial Inc. |
| Richard Shannon | Craig-Hallum Capital Group LLC |